PROS1 and lymphoma: These findings are in accordance with a recent review on the pathophysiological mechanisms underpinning thrombosis in untreated lymphoma and leukemia patients with active disease, which concluded that these patients appear to display a hypercoagulable phenotype including significant elevations in FVIII and D-dimer levels and reduced protein S levels.